Skip to content
Home/Companies/Diagnostics, Animal & Environmental Health/EUROLyser
EUROLyser

EUROLyser

Diagnostics, Animal & Environmental Health·Austria·Exited 2022·Held 3yr
Entry
2019
Hold
3yr
Exit
2022

Who owns EUROLyser?

EUROLyser was owned by ARCHIMED through MED Platform I (2019 vintage) from 2019 to 2022, exited via Trade Sale.

Buyer identity and MOIC available on Pro.

Hand-verified · updated 2026-04-21

ARCHIMED
Investor
ARCHIMED
MED Platform I · 2019 · Buyout

Key facts

HQAustria
SectorDiagnostics, Animal & Environmental Health
Websitewww.eurolyser.com
Exit Type
Trade Sale
Buyer
MOIC
Exit Year
2022

More from MED Platform I

Other portfolio companies in the same fund.

CARSO
Carso
Active
MedTechFrance· 2021
Ad-Tech Medical Instrument
Exited 2024
MedTechUS· 2020
to
Ametris (ActiGraph)
Ametris (ActiGraph)
Exited 2026
HealthTechUS· 2020
to
Namsa
Active
MedTechUS· 2020
ZYTOMICS
Zytomics
Active
MedTechGermany· 2020
Bomi Group
Exited 2023
MedTechItaly· 2019
to

More PE-backed in MedTech

Comparable medtech deals from other GPs.

Acufocus, Inc.
Exited 2023
The Carlyle GroupUS
to
Adicon Holdings Limited
Active
The Carlyle GroupUS
Aesynt
Exited 2016
Francisco PartnersUS
to
Alere Medical, Inc.
Active
TA AssociatesUS
Alma Lasers, Ltd.
Alma Lasers, Ltd.
Active
TA AssociatesIsrael
Amedes Group
Active
General AtlanticGermany
Track EUROLyser

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Get the full record on EUROLyser.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyer and MOIC on this deal (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue